CLINICAL_TRIALS
trial_result
· 2012-08-14
Clinical Trial Update: Sunitinib in Treating Patients With Idiopathic Myelofibrosis [Phase 2]
Summary
Phase 2 trial of sunitinib in patients with primary myelofibrosis was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2012-08-14